Dr. Filiz Yarımçan

My 82-year-old father was admitted with unexplained weight loss and fatigue. Multiple doctors were stumped. Dr. Yarımçan didn't just look at his biopsy slides—she requested his entire medical history going back ten years. She spent three hours comparing tissue samples from different periods and discovered a rare, slow-growing neuroendocrine tumor that others had missed for years. Her report was so detailed it read like a detective novel, connecting dots no one else saw. She even called his cardiologist to discuss how the tumor might be affecting his heart medication. We finally have answers after two years of uncertainty.

Our 7-year-old daughter needed a lymph node biopsy after a persistent swelling. We were terrified of cancer. Dr. Filiz met us in her office before the procedure, showing us colorful diagrams of cells to explain what she'd be looking for. When the results came back, she didn't just send a report—she created a simple, illustrated summary showing 'good guy' cells fighting off an infection. She found an unusual fungal presence that typical tests missed, requiring specific treatment. Her ability to translate complex pathology into a story our child could understand turned a traumatic experience into a learning adventure. She's a doctor who sees the patient, not just the slide.

I came for a routine colonoscopy follow-up, expecting the usual 'all clear.' Instead, Dr. Yarımçan identified focal crypt dysplasia in one polyp—a precancerous change so minute it was nearly invisible. What impressed me was her methodology: she used five different staining techniques and digital image analysis, then consulted with a specialist in Germany via a shared slide platform. She explained the molecular markers with such clarity that I understood my 0.3% increased risk without feeling alarmed. Her proactive approach meant I need only annual surveillance instead of major intervention. She treats routine cases with extraordinary attention.

After a complex Whipple procedure for pancreatic issues, my surgical team was confident they'd removed all concerning tissue. Dr. Yarımçan's margin analysis told a different story. Using intraoperative frozen sections and then exhaustive permanent sectioning, she found microscopic tumor cells at one duct margin—cells that resembled normal tissue under standard examination. She insisted on re-excision, delaying surgery closure by 90 minutes. The second set of margins came back clear. My oncologist said her stubborn precision likely prevented recurrence. She has the courage to contradict surgeons when the tissue tells a different story, and the expertise to prove it.